[{"Assets_0_Q1_USD":688523000.0,"CommonStockSharesConverted_0_Q1_shares":125262537.0,"CommonStockSharesOutstanding_0_Q1_shares":125262537.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-40809000.0,"NetIncomeLossConverted_1_Q1_USD":-54480000.0,"StockholdersEquity_0_Q1_USD":606519000.0,"EarningsPerShareBasic_1_Q1_USD":-0.5,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]